Treating Relapsed/Refractory Myeloma
Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape

Released: October 24, 2022

Expiration: October 23, 2023

Natalie S. Callander
Natalie S. Callander, MD
Noopur Raje
Noopur Raje, MD
Paul G. Richardson
Paul G. Richardson, MD

Activity

Progress
1
Course Completed

In this podcast episode from Clinical Care Options, Paul G. Richardson, MD; Natalie S. Callander, MD; and Noopur Raje, MD, answer questions from a live webinar on therapeutic options currently available for patients with relapsed/refractory multiple myeloma. The topics covered include:

  • How to sequence currently available therapies after relapse
  • Challenges with using BCMA-targeted agents in clinical practice
  • Experts’ thoughts on the potential approval of bispecific agents